Brilliant Violet 421??? anti-human CD3 and 5 more items

BioLegend Inc. was awarded a purchase order (PO-0451700) by the University of Virginia on June 25, 2026, for the procurement of specialized flow cytometry antibodies and reagents. The contract, valued at $2,312.70, encompasses six distinct line items of fluorescently-labeled monoclonal antibodies designed for immunological research applications. The materials are to be delivered to Ryan M. Sangston at the University of Virginia in Virginia. The product portfolio includes human-targeted antibodies such as Brilliant Violet 421 anti-human CD3 (4 units at $266.70 per unit), Brilliant Violet 510 and 650 anti-human CD69 variants, Ultra-LEAF Purified anti-human HLA-A,B,C, and mouse-targeted reagents including Brilliant Violet 605 anti-mouse T-cell receptor beta chain and PE (phycoerythrin) anti-mouse T-cell receptor beta chain.

These reagents support flow cytometric analysis and immunophenotyping applications commonly utilized in academic medical research. The contract represents a standard procurement of specialized laboratory reagents necessary for cellular immunology research programs. No specific performance period is indicated in the award documentation, though the transaction represents a one-time purchase order rather than a recurring service arrangement. The University of Virginia, as the contracting organization, procured these materials through BioLegend Inc., a recognized supplier of life science research products.